One of the world’s biggest pharmaceutical companies says a vaccine to tackle Ebola will “come too late” to curb the current epidemic, as the UK and other European countries begin screening passengers for the virus at international airports. GlaxoSmithKline (GSK), a British multinational that produces pharmaceuticals, biologics and vaccines, said a working vaccine would not be readily available until late 2015, by which time the epidemic may have spread far beyond West Africa. The statement follows warnings from the United Nations and World Health Organization (WHO) that there could soon be more than 10,000 new cases of Ebola per week if the spread of the disease is not curbed quickly. “We either stop Ebola now or we face an entirely unprecedented situation for which we do not have a plan,” said the UN’s Deputy Ebola Coordinator Anthony Banbury on Wednesday. “The WHO advises within 60 days we must ensure 70 percent of infected people are in a care facility and 70 percent of burials are done without causing further infection,” he added. More
Never Miss A Headline!
Subscribe to our daily digest! Sign up FREE today.